| __timestamp | Intra-Cellular Therapies, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 79838000 |
| Thursday, January 1, 2015 | 139626 | 121816000 |
| Friday, January 1, 2016 | 93831530 | 117633000 |
| Sunday, January 1, 2017 | 79419009 | 4577000 |
| Monday, January 1, 2018 | 368673 | 12670000 |
| Tuesday, January 1, 2019 | 477121 | 12135000 |
| Wednesday, January 1, 2020 | 1895029 | 18942000 |
| Friday, January 1, 2021 | 8034589 | 32328000 |
| Saturday, January 1, 2022 | 20443000 | 44678000 |
| Sunday, January 1, 2023 | 33745000 | 65486000 |
Data in motion
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the cost of revenue for two pioneering companies: Intra-Cellular Therapies, Inc. and PTC Therapeutics, Inc., from 2014 to 2023.
Intra-Cellular Therapies, Inc. has shown a remarkable increase in its cost of revenue, growing from a modest $140,000 in 2015 to over $33 million in 2023. This represents a staggering increase of over 23,000%, reflecting the company's expanding operations and market reach. Meanwhile, PTC Therapeutics, Inc. experienced fluctuations, with a peak cost of revenue in 2015 at approximately $122 million, followed by a more stable trend, reaching around $65 million in 2023.
These trends highlight the evolving financial landscapes of these companies, offering insights into their operational strategies and market positioning.
Cost Insights: Breaking Down Merck & Co., Inc. and PTC Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Sanofi vs Intra-Cellular Therapies, Inc.
GSK plc vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs HUTCHMED (China) Limited
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Comparison: PTC Therapeutics, Inc. vs MorphoSys AG
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Travere Therapeutics, Inc.